米非司酮治疗子宫肌瘤的临床效果观察100例

The clinical effect of mifepristone in the treatment of 100 paitents with uterine fibroids

目的:探讨米非司酮对子宫肌瘤的临床治疗效果。方法:收治子宫肌瘤患者200例,随机平分为两组,研究组口服米非司酮、对照组服用丹那唑,对疗效,肌瘤大小和患者血红蛋白水平进行研究。结果:研究组疗效显著率及总有效率高于观察组;研究组治疗前后的肿瘤体积以及血红蛋白水平均具有明显改善,效果明显好于对照组,差异有统计学意义(P<0.05)。结论:米非司酮治疗子宫肌瘤可以明显缩小肌瘤体积,还可改善患者的贫血情况。

Objective:To investigate the clinical therapeutic effect of mifepristone in the treatment of paitents with uterine fibroids.Methods:200 paitents with uterine fibroids were selected,they were randomly divided into two groups on average,patients in the study group were treated with mifepristone and patients in the control group were treated with danazol.We studied the effects of treatment,the size of the myoma and the hemoglobin level of patients.Results:The efficacy rate and total effective rate of the study group were higher than that of the observation group.The tumor volume and hemoglobin level in the study group were significantly improved,and the effect was significantly better than the control group,the differences were statistically significant(P<0.05).Conclusion:Mifepristone in the treatment of paitents with uterine fibroids can significantly reduce the size of the fibroids,but also improve the patients with anemia.